1. Home
  2. VCYT
  3. VCYT News

Latest Veracyte Inc. (VCYT) News on March 27, 2025

VCYT

MT Newswires

2 days ago

Veracyte Cancer Diagnostic Platform Shows Higher Specificity Than Blood Tests

New Data Demonstrate Accuracy of Veracyte’s Whole-Genome Sequencing-Based MRD Testing Platform for Muscle-Invasive Bladder Cancer
VCYT

Business Wire

2 days ago

New Data Demonstrate Accuracy of Veracyte’s Whole-Genome Sequencing-Based MRD Testing Platform for Muscle-Invasive Bladder Cancer

US High Growth Tech Stocks With Promising Potential
VCYT

Simply Wall St.

2 days ago

US High Growth Tech Stocks With Promising Potential

GMED Stock Jumps 41.8% in a Year: What's Behind the Rally?
VCYT

Zacks

6 days ago

GMED Stock Jumps 41.8% in a Year: What's Behind the Rally?

VCYT

MT Newswires

7 days ago

Craig-Hallum Initiates Veracyte at Buy With $45 Price Target

Veracyte Announces Eight Abstracts Highlighting Performance and Clinical Utility of Its Decipher and MRD Tests in Urologic Cancers To Be Presented at EAU25
VCYT

Business Wire

8 days ago

Veracyte Announces Eight Abstracts Highlighting Performance and Clinical Utility of Its Decipher and MRD Tests in Urologic Cancers To Be Presented at EAU25

Veracyte Stock Surges 45.6% in a Year: What's Driving the Rally?
VCYT

Zacks

14 days ago

Veracyte Stock Surges 45.6% in a Year: What's Driving the Rally?

Veracyte (VCYT) Surged on Reporting Strong Earnings
VCYT

Insider Monkey

17 days ago

Veracyte (VCYT) Surged on Reporting Strong Earnings

Veracyte Full Year 2024 Earnings: EPS Misses Expectations
VCYT

Simply Wall St.

23 days ago

Veracyte Full Year 2024 Earnings: EPS Misses Expectations

Veracyte's (NASDAQ:VCYT) Performance Is Even Better Than Its Earnings Suggest
VCYT

Simply Wall St.

24 days ago

Veracyte's (NASDAQ:VCYT) Performance Is Even Better Than Its Earnings Suggest

Top 3 Medical Instruments Industry Stocks to Ride the GenAI Boom
VCYT

Zacks

a month ago

Top 3 Medical Instruments Industry Stocks to Ride the GenAI Boom

VCYT

Thomson Reuters StreetEvents

a month ago

Q4 2024 Veracyte Inc Earnings Call

VCYT

MT Newswires

a month ago

UBS Adjusts Veracyte Price Target to $49 From $46, Maintains Buy Rating

Veracyte Stock Falls Despite Q4 Earnings and Revenue Beat
VCYT

Zacks

a month ago

Veracyte Stock Falls Despite Q4 Earnings and Revenue Beat

Veracyte Inc (VCYT) Q4 2024 Earnings Call Highlights: Record Revenue Growth and Strategic ...
VCYT

GuruFocus.com

a month ago

Veracyte Inc (VCYT) Q4 2024 Earnings Call Highlights: Record Revenue Growth and Strategic ...

VCYT

MT Newswires

a month ago

Veracyte Q4 Non-GAAP Earnings, Revenue Rise; Shares Fall After-Hours

Veracyte (VCYT) Q4 Earnings and Revenues Beat Estimates
VCYT

Zacks

a month ago

Veracyte (VCYT) Q4 Earnings and Revenues Beat Estimates

VCYT

Associated Press Finance

a month ago

Veracyte: Q4 Earnings Snapshot

Veracyte Announces Fourth Quarter and Full Year 2024 Financial Results
VCYT

Business Wire

a month ago

Veracyte Announces Fourth Quarter and Full Year 2024 Financial Results

What To Expect From Veracyte Inc (VCYT) Q4 2024 Earnings
VCYT

GuruFocus.com

a month ago

What To Expect From Veracyte Inc (VCYT) Q4 2024 Earnings

Is Veracyte Stock a Good Addition to Your Portfolio Right Now?
VCYT

Zacks

a month ago

Is Veracyte Stock a Good Addition to Your Portfolio Right Now?

High Growth Tech Stocks To Watch In February 2025
VCYT

Simply Wall St.

a month ago

High Growth Tech Stocks To Watch In February 2025

Veracyte to Participate in Upcoming Investor Conferences
VCYT

Business Wire

a month ago

Veracyte to Participate in Upcoming Investor Conferences

Schrodinger Stock Scores IBD Rating Upgrade
VCYT

Investor's Business Daily

a month ago

Schrodinger Stock Scores IBD Rating Upgrade

New Data at ASCO GU Show Power of Veracyte’s Decipher Tests to Improve Patient Care and Its GRID Tool to Advance Prostate and Bladder Cancer Research
VCYT

Business Wire

a month ago

New Data at ASCO GU Show Power of Veracyte’s Decipher Tests to Improve Patient Care and Its GRID Tool to Advance Prostate and Bladder Cancer Research

Best Momentum Stocks to Buy for February 13th
VCYT

Zacks

a month ago

Best Momentum Stocks to Buy for February 13th

Veracyte Announces 17 Abstracts Demonstrating Its Decipher Tests’ Leadership in Urologic Cancers to Be Presented at the 2025 ASCO GU Symposium
VCYT

Business Wire

a month ago

Veracyte Announces 17 Abstracts Demonstrating Its Decipher Tests’ Leadership in Urologic Cancers to Be Presented at the 2025 ASCO GU Symposium

New Study Shows Veracyte’s Decipher Bladder Test Predicts Disease Upstaging in Patients with Bladder Cancer
VCYT

Business Wire

2 months ago

New Study Shows Veracyte’s Decipher Bladder Test Predicts Disease Upstaging in Patients with Bladder Cancer

Veracyte to Release Fourth Quarter and Full-Year 2024 Financial Results on February 24, 2025
VCYT

Business Wire

2 months ago

Veracyte to Release Fourth Quarter and Full-Year 2024 Financial Results on February 24, 2025

VCYT

Zacks

2 months ago

Brian's Big Idea: Healthcare Stocks

VCYT

MT Newswires

2 months ago

Needham Boosts Price Target on Veracyte to $51 From $44, Keeps Buy Rating

3 US Stocks Estimated To Be Undervalued By Up To 49.9% Presenting An Opportunity
VCYT

Simply Wall St.

2 months ago

3 US Stocks Estimated To Be Undervalued By Up To 49.9% Presenting An Opportunity

Exploring High Growth Tech Stocks in January 2025
VCYT

Simply Wall St.

2 months ago

Exploring High Growth Tech Stocks in January 2025

GMED Stock Rides on NuVasive Synergy Benefits Amid Macro Issues
VCYT

Zacks

3 months ago

GMED Stock Rides on NuVasive Synergy Benefits Amid Macro Issues

Veracyte, Inc. (NASDAQ:VCYT) Has Found A Path To Profitability
VCYT

Simply Wall St.

3 months ago

Veracyte, Inc. (NASDAQ:VCYT) Has Found A Path To Profitability

The Zacks Rank Explained: How to Find Strong Buy Medical Stocks
VCYT

Zacks

3 months ago

The Zacks Rank Explained: How to Find Strong Buy Medical Stocks

Veracyte Gains 44% in a Year: What's Driving the Stock?
VCYT

Zacks

3 months ago

Veracyte Gains 44% in a Year: What's Driving the Stock?

Macroeconomic Woes, FX Headwind Drag NEOG Stock Down
VCYT

Zacks

3 months ago

Macroeconomic Woes, FX Headwind Drag NEOG Stock Down

Phibro Animal Health Gains 83% in a Year: What's Driving the Stock?
VCYT

Zacks

3 months ago

Phibro Animal Health Gains 83% in a Year: What's Driving the Stock?

Should You Retain Labcorp Stock in Your Portfolio Right Now?
VCYT

Zacks

3 months ago

Should You Retain Labcorp Stock in Your Portfolio Right Now?

Here's Why VCYT Stock Could be a Great Addition to Your Portfolio Now
VCYT

Zacks

3 months ago

Here's Why VCYT Stock Could be a Great Addition to Your Portfolio Now

The Zacks Analyst Blog Highlights Veracyte, Omnicell, Masimo and Abbott Laboratories
VCYT

Zacks

3 months ago

The Zacks Analyst Blog Highlights Veracyte, Omnicell, Masimo and Abbott Laboratories

Is Your Portfolio Missing These 5 High-Growth Healthcare Stocks?
VCYT

Zacks

3 months ago

Is Your Portfolio Missing These 5 High-Growth Healthcare Stocks?

4 Healthcare Technology Innovators to Invest in Before the New Year
VCYT

Zacks

3 months ago

4 Healthcare Technology Innovators to Invest in Before the New Year

The Zacks Analyst Blog Highlights McKesson, Doximity and Veracyte
VCYT

Zacks

3 months ago

The Zacks Analyst Blog Highlights McKesson, Doximity and Veracyte

3 Medical Instruments Industry Stocks to Buy on the GenAI Wave
VCYT

Zacks

3 months ago

3 Medical Instruments Industry Stocks to Buy on the GenAI Wave

Exploring Three High Growth Tech Stocks In The United States
VCYT

Simply Wall St.

3 months ago

Exploring Three High Growth Tech Stocks In The United States

US Exchange: 3 Stocks That May Be Trading Below Fair Value
VCYT

Simply Wall St.

3 months ago

US Exchange: 3 Stocks That May Be Trading Below Fair Value

Why Veracyte, With 55% Growth In 2024, Is An Outlier In Cancer Diagnostics
VCYT

Investor's Business Daily

3 months ago

Why Veracyte, With 55% Growth In 2024, Is An Outlier In Cancer Diagnostics

Veracyte (VCYT) Shares Rebounded in Q3
VCYT

Insider Monkey

3 months ago

Veracyte (VCYT) Shares Rebounded in Q3

The Zacks Analyst Blog Intuitive Surgical, Globus Medical, Glaukos, Veracyte and Inogen
VCYT

Zacks

4 months ago

The Zacks Analyst Blog Intuitive Surgical, Globus Medical, Glaukos, Veracyte and Inogen

Those who invested in Veracyte (NASDAQ:VCYT) a year ago are up 68%
VCYT

Simply Wall St.

4 months ago

Those who invested in Veracyte (NASDAQ:VCYT) a year ago are up 68%

This Top Medical Stock is a #1 (Strong Buy): Why It Should Be on Your Radar
VCYT

Zacks

4 months ago

This Top Medical Stock is a #1 (Strong Buy): Why It Should Be on Your Radar

If You Invested $1000 in Veracyte a Decade Ago, This is How Much It'd Be Worth Now
VCYT

Zacks

4 months ago

If You Invested $1000 in Veracyte a Decade Ago, This is How Much It'd Be Worth Now

5 Medical Device Stocks That Survived the 2024 Market Volatility
VCYT

Zacks

4 months ago

5 Medical Device Stocks That Survived the 2024 Market Volatility

Veracyte’s Decipher Prostate Test Is Now the Only Gene Expression Test Recommended in NCCN® Prostate Cancer Guidelines
VCYT

Business Wire

4 months ago

Veracyte’s Decipher Prostate Test Is Now the Only Gene Expression Test Recommended in NCCN® Prostate Cancer Guidelines

VCYT

MT Newswires

4 months ago

Goldman Sachs Downgrades Veracyte to Neutral From Buy, Trims Price Target to $37 From $38

Four Reasons To Watch This AI Play. A Fresh Breakout Is Just One.
VCYT

Investor's Business Daily

4 months ago

Four Reasons To Watch This AI Play. A Fresh Breakout Is Just One.

VCYT

MT Newswires

4 months ago

Morgan Stanley Lifts Price Target on Veracyte to $28 From $26, Keeps Underweight Rating

VCYT

MT Newswires

4 months ago

Wolfe Research Initiates Veracyte at Outperform With $50 Price Target

VCYT

MT Newswires

4 months ago

Veracyte Insider Sold Shares Worth $585,663, According to a Recent SEC Filing

High Growth Tech Stocks To Watch In November 2024
VCYT

Simply Wall St.

4 months ago

High Growth Tech Stocks To Watch In November 2024

US Stocks Possibly Trading Below Fair Value Estimates In November 2024
VCYT

Simply Wall St.

4 months ago

US Stocks Possibly Trading Below Fair Value Estimates In November 2024

Veracyte, Inc. Just Recorded A 296% EPS Beat: Here's What Analysts Are Forecasting Next
VCYT

Simply Wall St.

5 months ago

Veracyte, Inc. Just Recorded A 296% EPS Beat: Here's What Analysts Are Forecasting Next

Veracyte Third Quarter 2024 Earnings: Beats Expectations
VCYT

Simply Wall St.

5 months ago

Veracyte Third Quarter 2024 Earnings: Beats Expectations

VCYT

MT Newswires

5 months ago

UBS Adjusts Price Target on Veracyte to $46 From $43, Maintains Buy Rating

Veracyte Q3 Earnings Beat Estimates, 2024 Guidance Raised
VCYT

Zacks

5 months ago

Veracyte Q3 Earnings Beat Estimates, 2024 Guidance Raised

Veracyte Inc (VCYT) Q3 2024 Earnings Call Highlights: Record Revenue Growth and Strategic Outlook
VCYT

GuruFocus.com

5 months ago

Veracyte Inc (VCYT) Q3 2024 Earnings Call Highlights: Record Revenue Growth and Strategic Outlook

Veracyte (VCYT) Tops Q3 Earnings and Revenue Estimates
VCYT

Zacks

5 months ago

Veracyte (VCYT) Tops Q3 Earnings and Revenue Estimates

VCYT

Associated Press Finance

5 months ago

Veracyte: Q3 Earnings Snapshot

Veracyte Announces Third Quarter 2024 Financial Results
VCYT

Business Wire

5 months ago

Veracyte Announces Third Quarter 2024 Financial Results

What To Expect From Veracyte Inc (VCYT) Q3 2024 Earnings
VCYT

GuruFocus.com

5 months ago

What To Expect From Veracyte Inc (VCYT) Q3 2024 Earnings

Veracyte to Participate in Upcoming Investor Conferences
VCYT

Business Wire

5 months ago

Veracyte to Participate in Upcoming Investor Conferences

Paragon 28, Inc. (FNA) Stock Jumps 7.2%: Will It Continue to Soar?
VCYT

Zacks

5 months ago

Paragon 28, Inc. (FNA) Stock Jumps 7.2%: Will It Continue to Soar?

Veracyte to Release Third Quarter 2024 Financial Results on November 6, 2024
VCYT

Business Wire

5 months ago

Veracyte to Release Third Quarter 2024 Financial Results on November 6, 2024

High Growth Tech Stocks To Watch In October 2024
VCYT

Simply Wall St.

5 months ago

High Growth Tech Stocks To Watch In October 2024

VCYT

MT Newswires

5 months ago

UBS Initiates Veracyte at Buy With $43 Price Target

Is Veracyte, Inc. (NASDAQ:VCYT) Trading At A 31% Discount?
VCYT

Simply Wall St.

5 months ago

Is Veracyte, Inc. (NASDAQ:VCYT) Trading At A 31% Discount?

How to Find Strong Buy Medical Stocks Using the Zacks Rank
VCYT

Zacks

6 months ago

How to Find Strong Buy Medical Stocks Using the Zacks Rank

VCYT

MT Newswires

6 months ago

Guggenheim Initiates Veracyte at Buy With $40 Price Target

Veracyte Inc (VCYT) Q2 2024 Earnings Call Highlights: Strong Revenue Growth and Raised Guidance
VCYT

GuruFocus.com

6 months ago

Veracyte Inc (VCYT) Q2 2024 Earnings Call Highlights: Strong Revenue Growth and Raised Guidance

Here's How Much a $1000 Investment in Veracyte Made 10 Years Ago Would Be Worth Today
VCYT

Zacks

6 months ago

Here's How Much a $1000 Investment in Veracyte Made 10 Years Ago Would Be Worth Today

Vanguard Group Inc's Strategic Acquisition of Veracyte Inc Shares
VCYT

GuruFocus.com

6 months ago

Vanguard Group Inc's Strategic Acquisition of Veracyte Inc Shares

New Data Presented at ASTRO 2024 Show that Veracyte’s Decipher Prostate Test Predicts Aggressive Prostate Cancer in African American Men
VCYT

Business Wire

6 months ago

New Data Presented at ASTRO 2024 Show that Veracyte’s Decipher Prostate Test Predicts Aggressive Prostate Cancer in African American Men

3 MedTech Stocks to Buy as Monetary Policy Eases
VCYT

Zacks

6 months ago

3 MedTech Stocks to Buy as Monetary Policy Eases

Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
VCYT

Zacks

6 months ago

Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick

Looking for Medical Stocks? The Zacks Rank Can Help You Find Winners
VCYT

Zacks

6 months ago

Looking for Medical Stocks? The Zacks Rank Can Help You Find Winners

Here's How Much You'd Have If You Invested $1000 in Veracyte a Decade Ago
VCYT

Zacks

6 months ago

Here's How Much You'd Have If You Invested $1000 in Veracyte a Decade Ago

Zacks Industry Outlook Intuitive Surgical, Masimo and Veracyte
VCYT

Zacks

6 months ago

Zacks Industry Outlook Intuitive Surgical, Masimo and Veracyte

New Data Presented at ESMO 2024 Show that Veracyte’s Decipher Prostate Test Predicts Chemotherapy Benefit in Patients with Metastatic Prostate Cancer
VCYT

Business Wire

6 months ago

New Data Presented at ESMO 2024 Show that Veracyte’s Decipher Prostate Test Predicts Chemotherapy Benefit in Patients with Metastatic Prostate Cancer

3 Medical Instruments Industry Stocks to Buy on genAI and M&A Boost
VCYT

Zacks

6 months ago

3 Medical Instruments Industry Stocks to Buy on genAI and M&A Boost

Exploring Three High Growth Tech Stocks in the United States
VCYT

Simply Wall St.

6 months ago

Exploring Three High Growth Tech Stocks in the United States

Here's Why VCYT Stock Could be a Great Addition to Your Portfolio Now
VCYT

Zacks

7 months ago

Here's Why VCYT Stock Could be a Great Addition to Your Portfolio Now

Insider Sale: Chief Commercial Officer-CLIA John Leite Sells Shares of Veracyte Inc (VCYT)
VCYT

GuruFocus.com

7 months ago

Insider Sale: Chief Commercial Officer-CLIA John Leite Sells Shares of Veracyte Inc (VCYT)

Veracyte (VCYT) Up 9.2% Since Last Earnings Report: Can It Continue?
VCYT

Zacks

7 months ago

Veracyte (VCYT) Up 9.2% Since Last Earnings Report: Can It Continue?

The Zacks Rank Explained: How to Find Strong Buy Medical Stocks
VCYT

Zacks

7 months ago

The Zacks Rank Explained: How to Find Strong Buy Medical Stocks

Should You Continue to Retain ABT Stock in Your Portfolio Now?
VCYT

Zacks

7 months ago

Should You Continue to Retain ABT Stock in Your Portfolio Now?

Veracyte Appoints Brent Shafer and Tom Miller, Ph.D., to Its Board of Directors
VCYT

Business Wire

7 months ago

Veracyte Appoints Brent Shafer and Tom Miller, Ph.D., to Its Board of Directors

Here's Why Veracyte (VCYT) is a Strong Momentum Stock
VCYT

Zacks

7 months ago

Here's Why Veracyte (VCYT) is a Strong Momentum Stock

5 Relative Price Strength Stocks That You Should Buy Now
VCYT

Zacks

7 months ago

5 Relative Price Strength Stocks That You Should Buy Now

Share on Social Networks: